Element | Score | CPDAI Score | PASDAS Score | AMDF Score |
---|---|---|---|---|
TJC | 0 | 0 | 0 | 1 |
SJC | 0 | 0 | 1 | |
HAQ | 0.4 | 2 | — | 0.84 |
LEI | 5 | 0.41 | — | |
Dactylitis | 0 | 0 | 0 | — |
PASI | 8 | 2 | — | — |
DLQI | 13 | — | — | |
BASDAI | 5.6 | 3 | — | — |
ASQoL | 14 | — | — | |
PsAQoL | 9 | — | — | 0.52 |
SF-36 PCS | 30 | — | 1.39 | 0.27 |
VAS patient global activity | 65 | — | 1.28 | 0.28 |
VAS patient skin disease activity | 10 | — | — | 0.8 |
VAS patient joint disease activity | 35 | — | — | 0.58 |
VAS physician global activity | 60 | — | 1.39 | — |
CRP | 25 | — | 0.33 | — |
CPDAI: Composite Psoriatic Disease Activity Index; PASDAS: Psoriatic Arthritis Disease Activity Score; AMDF: arithmetic mean of desirability functions; TJC: tender joint count; SJC: swollen joint count; HAQ: Health Assessment Questionnaire; LEI: Leeds Enthesitis Index; PASI: Psoriasis Area and Severity Index; DLQI: Dermatology Life Quality Index; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index; ASQoL: Ankylosing Spondylitis Quality of Life; PsAQoL: Psoriatic Arthritis Quality of Life; SF-36 PCS: Medical Outcome Study Short Form-36 Survey physical component score; VAS: visual analog scale; CRP: C-reactive protein.